| scholarly article | Q13442814 |
| P356 | DOI | 10.3171/JNS/2008/108/2/0227 |
| P698 | PubMed publication ID | 18240916 |
| P50 | author | Edward Chang | Q87411690 |
| P2093 | author name string | Mitchel S Berger | |
| Nicholas M Barbaro | |||
| Susan M Chang | |||
| Kathleen R Lamborn | |||
| G Evren Keles | |||
| Matthew B Potts | |||
| P2860 | cites work | Brain tumor and seizures: pathophysiology and its implications for treatment revisited | Q35200145 |
| P433 | issue | 2 | |
| P921 | main subject | patient | Q181600 |
| seizure | Q6279182 | ||
| P304 | page(s) | 227-235 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | Journal of Neurosurgery | Q15708886 |
| P1476 | title | Seizure characteristics and control following resection in 332 patients with low-grade gliomas | |
| P478 | volume | 108 |
| Q39031402 | 'Low grade glioma': an update for radiologists |
| Q37690203 | A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures |
| Q38456018 | Anaplastic glioma: current treatment and management |
| Q37714906 | Anaplastic oligodendroglioma |
| Q61809517 | Anatomical features of primary brain tumors affect seizure risk and semiology |
| Q96952362 | Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy |
| Q48238896 | Awake mapping optimizes the extent of resection for low-grade gliomas in eloquent areas |
| Q38488233 | BCL2A1 is a potential biomarker for postoperative seizure control in patients with low-grade gliomas |
| Q37174060 | Brain tumors and epilepsy |
| Q34014740 | Central nervous system cancers |
| Q88990486 | Choice of antiepileptic drugs affects the outcome in cancer patients with seizures |
| Q48914486 | Clinical and molecular genetic factors affecting postoperative seizure control of 183 Chinese adult patients with low-grade gliomas |
| Q47827300 | Clinical characteristics associated with postoperative seizure control in adult low-grade gliomas: a systematic review and meta-analysis. |
| Q33815954 | Clinical prognostic factors of adjuvant radiation therapy for low-grade gliomas: results of 10 years survival |
| Q58713653 | Comprehensive evaluation of treatment and outcomes of low-grade diffuse gliomas |
| Q91668168 | Continuous EEG monitoring after brain tumor surgery |
| Q90729043 | Correlation between glioma location and preoperative seizures: a systematic review and meta-analysis |
| Q38662901 | Critical Care Management of Cerebral Edema in Brain Tumors |
| Q47860829 | Current Management of Adult Diffuse Infiltrative Low Grade Gliomas |
| Q34830708 | Current treatment of low grade gliomas |
| Q93122875 | Dealing with the storm: An overview of seizure precipitants and spontaneous seizure worsening in drug-resistant epilepsy |
| Q41685604 | Deficiency of very large G-protein-coupled receptor-1 is a risk factor of tumor-related epilepsy: a whole transcriptome sequencing analysis |
| Q64255604 | Diffuse Low-Grade Glioma - Changing Concepts in Diagnosis and Management: A Review |
| Q39159242 | Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies |
| Q45716565 | Early and late postoperative seizure outcome in 97 patients with supratentorial meningioma and preoperative seizures: a retrospective study |
| Q24186964 | Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas |
| Q24236013 | Early versus delayed radiotherapy for the treatment of low-grade gliomas |
| Q89595065 | Effect of radiotherapy on freedom from seizures in dogs with brain tumors |
| Q97641157 | Effect of seizure timing on long-term survival in patients with brain tumor |
| Q38623570 | Emerging Treatments for Neuropathic Pain |
| Q87415858 | Epilepsy and brain tumors |
| Q38269055 | Epilepsy associated tumors: Review article |
| Q89604234 | Epilepsy in brain metastasis: an emerging entity |
| Q36893208 | Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy |
| Q37968607 | Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment |
| Q38149924 | Epilepsy in primary cerebral tumors: the characteristics of epilepsy at the onset (results from the PERNO study--Project of Emilia Romagna Region on Neuro-Oncology). |
| Q92446385 | Epilepsy in the end of life phase of brain tumor patients: a systematic review |
| Q38039263 | Epilepsy meets cancer: when, why, and what to do about it? |
| Q37497546 | Epileptic seizures and survival in early disease of grade 2 gliomas |
| Q38827937 | Extent of Resection in Glioma-A Review of the Cutting Edge. |
| Q45278576 | Extent of resection and survival in supratentorial infiltrative low-grade gliomas: analysis of and adjustment for treatment bias |
| Q37945513 | Extent of surgical resection predicts seizure freedom in low-grade temporal lobe brain tumors |
| Q30847166 | Factors associated with failed focal neocortical epilepsy surgery |
| Q37052309 | Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article |
| Q35238925 | Frequency, clinical correlates, and ratings of behavioral changes in primary brain tumor patients: a preliminary investigation |
| Q37381057 | Frequency, prognosis and surgical treatment of structural abnormalities seen with magnetic resonance imaging in childhood epilepsy |
| Q27335346 | GABAergic disinhibition and impaired KCC2 cotransporter activity underlie tumor-associated epilepsy. |
| Q28085270 | Glial tumors in brodmann area 6: spread pattern and relationships to motor areas |
| Q52568033 | Glioma-related seizures in relation to histopathological subtypes: a report from the glioma international case-control study. |
| Q48850051 | Glioma-related seizures: glutamate is the key. |
| Q46820292 | Glioma. |
| Q28081953 | Gliomas and the vascular fragility of the blood brain barrier |
| Q64233474 | Glutamate weighted imaging contrast in gliomas with 7 Tesla magnetic resonance imaging |
| Q52147368 | Gross-total resection of temporal low grade gliomas is a critically important factor in achieving seizure-freedom. |
| Q44401707 | Higher incidence of epilepsy in meningiomas located on the premotor cortex: a voxel-wise statistical analysis |
| Q47419073 | IDH1 and IDH2 mutations in postoperative diffuse glioma-associated epilepsy. |
| Q97070223 | Identification of neural networks preferentially engaged by epileptogenic mass lesions through lesion network mapping analysis |
| Q40186790 | Improved Survival with Decreased Wait Time to Surgery in Glioblastoma Patients Presenting with Seizure. |
| Q30381936 | Incidental diffuse low-grade gliomas: from early detection to preventive neuro-oncological surgery. |
| Q36095490 | Intraoperative high-field magnetic resonance imaging combined with functional neuronavigation in resection of low-grade temporal lobe tumors |
| Q37590603 | Is there a response shift in generic health-related quality of life 6 months after glioma surgery? |
| Q34886729 | Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping |
| Q26766290 | Long-range and short-range tumor-stroma networks synergistically contribute to tumor-associated epilepsy |
| Q50073765 | Long-term control and predictors of seizures in intracranial meningioma surgery: a population-based study |
| Q90310319 | Long-term seizure outcome in frontal lobe epilepsy surgery |
| Q48440857 | Long-term surgical outcomes of temporal lobe epilepsy associated with low-grade brain tumors. |
| Q41169134 | Low-grade Glioma Surgery in Intraoperative Magnetic Resonance Imaging: Results of a Multicenter Retrospective Assessment of the German Study Group for Intraoperative Magnetic Resonance Imaging. |
| Q87512174 | Low-grade gliomas |
| Q81521000 | Low-grade gliomas in adults |
| Q33684199 | Management of Diffuse Low-Grade Cerebral Gliomas |
| Q41837210 | Managing common complex symptomatic epilepsies: tumors and trauma: american epilepsy society - 2012 annual course summary. |
| Q31095748 | Maximizing safe resection of low- and high-grade glioma |
| Q89489899 | Molecular Aberrations Associated with Seizure Control in Diffuse Astrocytic and Oligodendroglial Tumors |
| Q34370327 | Morphological characteristics of brain tumors causing seizures |
| Q46022640 | Mutant IDH1 and seizures in patients with glioma. |
| Q44347317 | Neoadjuvant chemotherapy may optimize the extent of resection of World Health Organization grade II gliomas: a case series of 17 patients. |
| Q46048169 | Neurocognitive Function in Newly Diagnosed Low-grade Glioma Patients Undergoing Surgical Resection With Awake Mapping Techniques |
| Q36381656 | Neurosurgical management of adult diffuse low grade gliomas in Canada: a multi-center survey |
| Q92863586 | Neurosurgical patterns of care for diffuse low-grade gliomas in Sweden between 2005 and 2015 |
| Q55462937 | New-onset epilepsy: considerations for initial and follow-up MRI to detect brain tumor. |
| Q37972794 | Outcomes after discontinuation of antiepileptic drugs after surgery in patients with low grade brain tumors and meningiomas |
| Q42069740 | Overall survival in adult patients with low-grade, supratentorial glioma: Ten years' follow up at a single institution |
| Q34019937 | Palliative care and quality of life in neuro-oncology |
| Q38217449 | Peritumoral epilepsy: relating form and function for surgical success. |
| Q38624657 | Post-operative seizures after burr hole evacuation of chronic subdural hematomas: is prophylactic anti-epileptic medication needed? |
| Q48496392 | Postoperative seizure control in patients with tumor-associated epilepsy |
| Q47367341 | Predicting the likelihood of postoperative seizure status based on mRNA sequencing in low-grade gliomas |
| Q48309717 | Prediction of anaplastic transformation in low-grade oligodendrogliomas based on magnetic resonance spectroscopy and 1p/19q codeletion status |
| Q38770563 | Predictors and mechanisms of epilepsy occurrence in cerebral gliomas: What to look for in clinicopathology |
| Q85215288 | Predictors of seizure freedom after incomplete resection in children |
| Q37681519 | Present day's standards in microsurgery of low-grade gliomas |
| Q48008911 | Prevalence, Characteristics, and Long-Term Prognosis of Epilepsy Associated with Pediatric Brain Tumors |
| Q83911864 | Primary brain tumours in adults |
| Q98291666 | Prognostic Nomograms for Primary High-Grade Glioma Patients in Adult: A Retrospective Study Based on the SEER Database |
| Q46073319 | Prophylactic anticonvulsants in patients with primary glioblastoma. |
| Q48120678 | Quality of life assessed with EQ-5D in patients undergoing glioma surgery: what is the responsiveness and minimal clinically important difference? |
| Q64899298 | Radiomics analysis allows for precise prediction of epilepsy in patients with low-grade gliomas. |
| Q38185341 | Rates and predictors of seizure freedom in resective epilepsy surgery: an update. |
| Q38695438 | Rates of Seizure Freedom after Surgical Resection of Diffuse Low-Grade Gliomas |
| Q55462054 | Recent innovations in the management of low-grade gliomas. |
| Q38170432 | Resection strategies in tumoral epilepsy: is a lesionectomy enough? |
| Q33865523 | Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. |
| Q30487017 | Role of subdural electrocorticography in prediction of long-term seizure outcome in epilepsy surgery. |
| Q37204965 | Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study |
| Q42227115 | Second Surgery in Insular Low-Grade Gliomas. |
| Q46475338 | Seizure Outcome After Surgical Resection of Insular Glioma. |
| Q92446516 | Seizure burden pre- and postresection of low-grade gliomas as a predictor of tumor progression in low-grade gliomas |
| Q37539618 | Seizure characteristics and control after microsurgical resection of supratentorial cerebral cavernous malformations |
| Q35696397 | Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study. |
| Q27024862 | Seizure characteristics and prognostic factors of gliomas |
| Q30275879 | Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials. |
| Q37312684 | Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study |
| Q83792352 | Seizure control for patients undergoing meningioma surgery |
| Q27027730 | Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review |
| Q90610207 | Seizure outcomes and survival in adult low-grade glioma over 11 years: living longer and better |
| Q33829789 | Seizure prognosis in brain tumors: new insights and evidence-based management |
| Q48641340 | Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide |
| Q36480099 | Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide |
| Q53740646 | Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations. |
| Q91901434 | Seizure response to temozolomide chemotherapy in patients with WHO grade II oligodendroglioma: a single-institution descriptive study |
| Q38769340 | Seizures and gliomas--towards a single therapeutic approach |
| Q37838691 | Seizures and the natural history of World Health Organization Grade II gliomas: a review |
| Q27023052 | Seizures in children with dysembryoplastic neuroepithelial tumors of the brain--A review of surgical outcomes across several studies |
| Q38055318 | Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments |
| Q38610571 | Seizures in oligodendroglial tumors |
| Q42102289 | Seizures in patients undergoing resection of low-grade gliomas |
| Q37681516 | Seizures in patients with low-grade gliomas--incidence, pathogenesis, surgical management, and pharmacotherapy. |
| Q36957738 | Seizures in supratentorial meningioma: a systematic review and meta-analysis |
| Q31104534 | Significance of miR-196b in tumor-related epilepsy of patients with gliomas |
| Q52097951 | Structured Evaluation of Glioma Patients by an Occupational Therapist-Is Our Clinical Examination Enough? |
| Q35038477 | Surgically treated incidentally discovered low-grade gliomas are mostly IDH mutated and 1p19q co-deleted with favorable prognosis |
| Q64120408 | Surgically treated intracranial supratentorial calcifying pseudoneoplasms of the neuraxis (CAPNON) with drug-resistant left temporal lobe epilepsy: A case report and review of the literature |
| Q38170431 | Systems biology of human epilepsy applied to patients with brain tumors. |
| Q48564405 | Temozolomide in low-grade gliomas: living longer and better |
| Q97527331 | The Ethical Dilemma in the Surgical Management of Low Grade Gliomas According to the Variable Availability of Resources and Surgeon Experience |
| Q47357519 | The Impact of Diffusion Tensor Imaging Fiber Tracking of the Corticospinal Tract Based on Navigated Transcranial Magnetic Stimulation on Surgery of Motor-Eloquent Brain Lesions |
| Q59807199 | The Impacts of Tumor and Tumor Associated Epilepsy on Subcortical Brain Structures and Long Distance Connectivity in Patients With Low Grade Glioma |
| Q48236780 | The Influence of Perioperative Seizure Prophylaxis on Seizure Rate and Hospital Quality Metrics Following Glioma Resection |
| Q49842640 | The Role of Extent of Resection in IDH1 Wild-Type or Mutant Low-Grade Gliomas. |
| Q37978808 | The challenge to remove diffuse low-grade gliomas while preserving brain functions |
| Q31016208 | The role of surgery in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline. |
| Q55461337 | The significance of IDH1 mutations in tumor-associated seizure in 60 Chinese patients with low-grade gliomas. |
| Q47235768 | The use of cannabidiol for seizure management in patients with brain tumor-related epilepsy |
| Q38916416 | The withdrawal of antiepileptic drugs in patients with low-grade and anaplastic glioma |
| Q30458916 | Therapeutic decision making in patients with newly diagnosed low grade glioma |
| Q92446398 | Time to focus on brain tumor-related epilepsy trials |
| Q38206723 | Treatment of epileptic seizures in brain tumors: a critical review |
| Q30984635 | Trends and Outcomes in the Treatment of Gliomas Based on Data during 2001–2004 from the Brain Tumor Registry of Japan |
| Q33828100 | Tumor associated seizures in glioblastomas are influenced by survival gene expression in a region-specific manner: a gene expression imaging study |
| Q37565310 | Tumor-associated epilepsy and glioma: are there common genetic pathways? |
| Q88802471 | Tumor-related epilepsy: epidemiology, pathogenesis and management |
| Q41676365 | Tumors generate excitement: the role of glutamate in tumor-related epilepsy |
| Q34322847 | Use of language mapping to aid in resection of gliomas in eloquent brain regions |
| Q87186237 | What is New in the Management of Epilepsy in Gliomas? |
| Q35225228 | Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study |
| Q64234109 | Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study |
| Q47128508 | Younger age at surgery and lesser seizure frequency as prognostic factors for favorable seizure-related outcome after glioma resection in adults |
Search more.